Literature DB >> 31686277

Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease.

Ha Q Vo1, Thomas H Marwick1,2, Kazuaki Negishi3,4.   

Abstract

T1 mapping by cardiac magnetic resonance (CMR) allows detection of abnormal myocardium. A number of myocardial abnormalities affects the signal captured in T1 mapping. We performed a systematic review and meta-analysis of native T1 and extracellular volume (ECV) in subjects with and without cardiac disease (1) to determine the normal ranges of T1 values and ECV by sequences as well as parameters influencing them, and (2) to summarize the differences in T1 values and ECV of the diseases relative to the normal ranges. Three databases (EMBASE, SCOPUS, and MEDLINE) were systematically searched for native T1 time and ECV. Only human studies with a sample size of ≥ 20 subjects were included. A random effect model was used to pool data. The 69 selected articles included 1954 healthy subjects and 3186 with disease. T1 of normal healthy was different among MOLLI variants: in 1.5T sequences, ShMOLLI had the shortest (944 ms [95% confidence interval 925, 963]), followed by MOLLI 3(3)3(3)5 flip-angle 50°, 967 [959, 975] and flip-angle 35°, 969 [951, 988]. 3T had longer T1 than 1.5T by approximately 100-200 ms. ECV of the normal healthy was consistent among the studies (ranging from 25 to 27%), irrespective of subjects' factors, sequences, vendors, and contrast type. Many diseases demonstrated longer native T1 than normal subjects, but T1 was shorter in Fabry disease and iron overload. In contrast, all disease states showed either normal or increased ECV. Diagnostic accuracy of native T1 time was minimally affected by the difference in the sequences. ECV is less influenced by methodology than T1 time among normal subjects. Different myocardial diseases are associated with shorter or longer T1 times, whereas ECV is consistently increased independent of the underlying pathophysiology.

Entities:  

Keywords:  Disease; ECV; Meta-analysis; Normal value; T1 mapping

Mesh:

Year:  2019        PMID: 31686277     DOI: 10.1007/s10554-019-01717-3

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  75 in total

Review 1.  T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review.

Authors:  Valentina O Puntmann; Elif Peker; Y Chandrashekhar; Eike Nagel
Journal:  Circ Res       Date:  2016-07-08       Impact factor: 17.367

2.  Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation.

Authors:  Nicola C Edwards; William E Moody; Mengshi Yuan; Peter Weale; Desley Neal; Jonathan N Townend; Richard P Steeds
Journal:  Circ Cardiovasc Imaging       Date:  2014-08-19       Impact factor: 7.792

3.  Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.

Authors:  Ify R Mordi; Satnam Singh; Amelia Rudd; Janaki Srinivasan; Michael Frenneaux; Nikolaos Tzemos; Dana K Dawson
Journal:  JACC Cardiovasc Imaging       Date:  2017-08-16

4.  Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.

Authors:  Songtao Liu; Jing Han; Marcelo S Nacif; Jacquin Jones; Nadine Kawel; Peter Kellman; Christopher T Sibley; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-12-28       Impact factor: 5.364

5.  T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

Authors:  Nadine Kawel; Marcelo Nacif; Anna Zavodni; Jacquin Jones; Songtao Liu; Christopher T Sibley; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2012-04-28       Impact factor: 5.364

6.  Native T1 and Extracellular Volume Measurements by Cardiac MRI in Healthy Adults: A Meta-Analysis.

Authors:  Matthew Gottbrecht; Christopher M Kramer; Michael Salerno
Journal:  Radiology       Date:  2018-11-13       Impact factor: 29.146

Review 7.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Authors:  James C Moon; Daniel R Messroghli; Peter Kellman; Stefan K Piechnik; Matthew D Robson; Martin Ugander; Peter D Gatehouse; Andrew E Arai; Matthias G Friedrich; Stefan Neubauer; Jeanette Schulz-Menger; Erik B Schelbert
Journal:  J Cardiovasc Magn Reson       Date:  2013-10-14       Impact factor: 5.364

8.  Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.

Authors:  Jonathan H Soslow; Stephen M Damon; Kimberly Crum; Mark A Lawson; James C Slaughter; Meng Xu; Andrew E Arai; Douglas B Sawyer; David A Parra; Bruce M Damon; Larry W Markham
Journal:  J Cardiovasc Magn Reson       Date:  2016-01-21       Impact factor: 5.364

9.  Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Authors:  Elaine Rutherford; Mohammed A Talle; Kenneth Mangion; Elizabeth Bell; Samuli M Rauhalammi; Giles Roditi; Christie McComb; Aleksandra Radjenovic; Paul Welsh; Rosemary Woodward; Allan D Struthers; Alan G Jardine; Rajan K Patel; Colin Berry; Patrick B Mark
Journal:  Kidney Int       Date:  2016-08-05       Impact factor: 10.612

10.  Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis.

Authors:  Calvin W L Chin; Scott Semple; Tamir Malley; Audrey C White; Saeed Mirsadraee; Peter J Weale; Sanjay Prasad; David E Newby; Marc R Dweck
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 6.875

View more
  6 in total

1.  Association of changes in the infarct and remote zone myocardial tissue with cardiac remodeling after myocardial infarction: a T1 and T2 mapping study.

Authors:  Ferhat Eyyupkoca; Gultekin Karakus; Murat Gok; Can Ozkan; Mehmet Sait Altintas; Aydin Rodi Tosu; Sercan Okutucu; Karabekir Ercan
Journal:  Int J Cardiovasc Imaging       Date:  2021-12-13       Impact factor: 2.357

Review 2.  Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis.

Authors:  Andrea Ponsiglione; Michele Gambardella; Roberta Green; Valeria Cantoni; Carmela Nappi; Raffaele Ascione; Marco De Giorgi; Renato Cuocolo; Antonio Pisani; Mario Petretta; Alberto Cuocolo; Massimo Imbriaco
Journal:  J Cardiovasc Magn Reson       Date:  2022-05-23       Impact factor: 6.903

3.  Exploring myocardial fibrosis in severe aortic stenosis: echo, CMR and histology data from FIB-AS study.

Authors:  Giedrė Balčiūnaitė; Justinas Besusparis; Darius Palionis; Edvardas Žurauskas; Viktor Skorniakov; Vilius Janušauskas; Aleksejus Zorinas; Tomas Zaremba; Nomeda Valevičienė; Pranas Šerpytis; Audrius Aidietis; Kęstutis Ručinskas; Peter Sogaard; Sigita Glaveckaitė
Journal:  Int J Cardiovasc Imaging       Date:  2022-03-03       Impact factor: 2.316

4.  T1 values and extracellular volume fraction in asymptomatic subjects: variations in left ventricular segments and correlation with cardiovascular risk factors.

Authors:  Moon Young Kim; Soo Jin Cho; Hae Jin Kim; Sung Mok Kim; Sang-Chol Lee; MunYoung Paek; Yeon Hyeon Choe
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

Review 5.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30

Review 6.  Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.

Authors:  Grigorios Korosoglou; Sorin Giusca; Florian André; Fabian Aus dem Siepen; Peter Nunninger; Arnt V Kristen; Norbert Frey
Journal:  Vasc Health Risk Manag       Date:  2021-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.